Assenagon Asset Management’s AC Immune ACIU Stock Holding History

Assenagon Asset Management’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-189,892	Closed	-$549K	–	1145
2025 Q3	$549K	Buy	+189,892	New	+$429K	﹤0.01%	1039
2024 Q4	–	Sell	-223,880	Closed	-$846K	–	1308
2024 Q3	$846K	Sell	223,880 -215,850	-49%	-$754K	﹤0.01%	1163
2024 Q2	$1.75M	Buy	439,730 +328,312	+295%	+$1.09M	﹤0.01%	950
2024 Q1	$330K	Hold	111,418	–	–	﹤0.01%	1272
2023 Q4	$557K	Hold	111,418	–	–	﹤0.01%	1240
2023 Q3	$318K	Hold	111,418	–	–	﹤0.01%	1277
2023 Q2	$329K	Hold	111,418	–	–	﹤0.01%	1221
2023 Q1	$261K	Sell	111,418 -480,626	-81%	-$1.11M	﹤0.01%	1330
2022 Q4	$1.21M	Buy	+592,044	New	+$1.53M	﹤0.01%	995
2022 Q3	–	Sell	-147,435	Closed	-$532K	–	1325
2022 Q2	$532K	Hold	147,435	–	–	﹤0.01%	1213
2022 Q1	$590K	Hold	147,435	–	–	﹤0.01%	1176
2021 Q4	$730K	Buy	+147,435	New	+$857K	﹤0.01%	1123
2020 Q4	–	Sell	-12,042	Closed	-$59K	–	986
2020 Q3	$59K	Buy	+12,042	New	+$86.4K	﹤0.01%	1095

Other funds holding ACIU

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Assenagon Asset Management's ACIU Position: Q4 2025 in Review

Assenagon Asset Management sold out of AC Immune (ACIU) in Q4 2025, closing a stake of 189,892 shares — an estimated $549K sold.

Assenagon Asset Management first reported a position in ACIU in Q3 2020 and held it in 13 quarters. The position peaked at $1.75M in Q2 2024. 42 funds tracked by Wall St. Rank hold ACIU as of Q4 2025.

Assenagon Asset Management reported no remaining AC Immune position as of Q4 2025 after selling out during the quarter.
Assenagon Asset Management sold 189,892 AC Immune shares in Q4 2025, an estimated $549K.
Assenagon Asset Management first reported a position in AC Immune in Q3 2020 and held it in 13 quarters.
Assenagon Asset Management's AC Immune position peaked at $1.75M in Q2 2024.
42 funds tracked by Wall St. Rank held AC Immune as of Q4 2025.

Based on Assenagon Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.